Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,069 | -46,566 | -23,251 | -57,060 | -38,811 |
| Depreciation Amortization | 67,828 | 1,014 | 509 | 16,992 | 16,488 |
| Income taxes - deferred | -12,661 | N/A | N/A | -4,282 | -4,282 |
| Accounts receivable | -1,057 | -100 | 777 | -1,029 | -136 |
| Other Working Capital | -1,996 | -1,555 | 82 | -4,275 | -2,487 |
| Other Operating Activity | 19,300 | 13,022 | 5,303 | -18,212 | -21,563 |
| Operating Cash Flow | $-57,655 | $-34,185 | $-16,580 | $-67,866 | $-50,791 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 87,675 | 71,749 | 61,055 | 118,566 | -48,025 |
| PPE Investments | -515 | -260 | -22 | -1,113 | -886 |
| Purchase Of Investment | N/A | -484 | N/A | -121,580 | N/A |
| Investing Cash Flow | $87,160 | $71,005 | $61,033 | $-4,127 | $-48,911 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,015 | 5,015 | 2,536 | 1,382 | 1,273 |
| Other Financing Activity | 18,549 | 0 | 0 | 54,264 | 54,264 |
| Financing Cash Flow | $23,564 | $5,015 | $2,536 | $55,646 | $55,537 |
| Exchange Rate Effect | 71 | 95 | 38 | -1,003 | -795 |
| Beginning Cash Position | 36,942 | 36,942 | 36,942 | 54,292 | 66,893 |
| End Cash Position | 90,082 | 78,872 | 83,969 | 36,942 | 21,933 |
| Net Cash Flow | $53,140 | $41,930 | $47,027 | $-17,350 | $-44,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,655 | -34,185 | -16,580 | -67,866 | -50,791 |
| Capital Expenditure | -526 | -271 | -31 | -1,138 | -911 |
| Free Cash Flow | -58,181 | -34,456 | -16,611 | -69,004 | -51,702 |